Navin Fluorine International Limited — Investor Meet, 11-06-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Navin Fluorine has announced a one-on-one analyst and investor meet to discuss its business. FY25 sales rose 14% YoY to Rs. 2,349 Cr with operating EBITDA up 34% at Rs. 534 Cr and margin expansion to 22.7%. Q4 sales grew 16% to Rs. 701 Cr, EBITDA surged 62% to Rs. 179 Cr. Growth was driven by Specialty Chemicals and CDMO segments, supported by new projects and a strong order book. Capex plans include Rs. 450 Cr for AHF plant by Q2 FY26 and Rs. 288 Cr for cGMP4 facility by Q3 FY26. A new advanced materials plant under a Chemours partnership is expected by Q1 FY27. Management underscores disciplined execution, robust order visibility, strong cash flow of Rs. 571 Cr, and focus on ESG and innovation, reflecting confident growth prospects.